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ABSTRACT The effect of ionic strength on the conformation and stability of S1 and S1–nucleotide–phosphate analog
complexes in solution was studied. It was found that increasing concentration of KCl enhances the reactivity of Cys707 (SH1
thiol) and Lys84 (reactive lysyl residue) and the nucleotide-induced tryptophan fluorescence increment. In contrast, high KCl
concentration lowers the structural differences between the intermediate states of ATP hydrolysis in the vicinity of Cys707,
Trp510 and the active site, possibly by increasing the flexibility of the molecule. High concentrations of neutral salts inhibit both
the formation and the dissociation of the M**.ADP.Pi analog S1.ADP.Vi complex. High ionic strength profoundly affects the
structure of the stable S1.ADP.BeFx complex, by destabilizing the M*.ATP intermediate, which is the predominant form of the
complex at low ionic strength, and shifting the equilibrium to favor the M**.ADP.Pi state. The M*.ATP intermediate is
destabilized by perturbation of ionic interactions possibly by disruption of salt bridges. Two salt-bridge pairs, Glu501–Lys505
in the Switch II helix and Glu776–Lys84 connecting the catalytic domain to the lever arm, seem most appropriate to consider
for participating in the ionic strength-induced transition of the open M*.ATP to the closed M**.ADP.Pi state of S1.
INTRODUCTION
Myosin is a motor protein responsible for powering muscle
contraction and a large number of motile events in eukary-
otic cells. The motor activity of myosin is based on its
interaction with actin, which is coupled with hydrolysis of
ATP. The myosin head, called subfragment 1 (S1), is where
the sites responsible for binding of actin and nucleotide are
located. (Myosin sequence numbering is from chicken pec-
toralis muscle (Maita et al., 1991) except where noted
otherwise.) The structure of S1 is highly dynamic and it
changes upon interaction with ATP, ADP- and phosphate-
analogs and actin. Conformational changes taking place
during the consecutive steps of myosin-catalyzed ATP hy-
drolysis were described by Bagshaw and Trentham (1974).
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M, M*.ATP, M**.ADP.Pi, and M*.ADP are intermedi-
ate states of ATP hydrolysis, having distinct spectral prop-
erties and representing different conformations (Werber et
al., 1972). The conformational changes occurring during the
transitions between the intermediate states of ATP hydro-
lysis are the source of force generation. Thus the description
of the conformation of myosin in the intermediate states is
essential for the understanding of the motor mechanism.
Structural analogs of phosphate (Pi)—vanadate (Vi), beryl-
lium fluoride (BeFx) and aluminum fluoride (AlF4) com-
plexes—were found to substitute Pi and stop the myosin-
catalyzed ATP hydrolysis by forming stable “trapped”
complexes with myosin and ADP (Goodno, 1979; Maruta et
al., 1993; Phan and Reisler, 1992; Werber et al., 1992). The
complexes of the recombinant truncated Dictyostelium S1
(S1dC) with BeFx, AlF4, and Vi—S1dC.ADP.BeFx,
S1dC.ADP.AlF4, S1dC.ADP.Vi—were crystallized, and
their atomic structure solved (Fisher et al., 1995; Smith and
Rayment, 1996). The structure of these complexes was
significantly different and indicated that S1dC.ADP.BeFx
resembles the M*.ATP, whereas S1dC.ADP.AlF4 and
S1dC.ADP.Vi mimic the M**ADP.Pi intermediate state.
However, it was shown recently that the atomic structures of
the crystallized smooth myosin S1 in complex with
ADP.AlF4 and ADP.BeFx are practically identical and
closely resemble those of S1dC.ADP.AlF4, and
S1dC.ADP.Vi (Dominguez et al., 1998). Very recently,
scallop myosin S1 complexed with ADP was crystallized in
a third conformation (Houdusse et al., 1999), which was
believed to be another ATP state of the molecule. Biochem-
ical studies of the relationship of the S1.ADP.PA complexes
to the states of ATP hydrolysis were carried out also on
rabbit skeletal muscle S1 in solution. The findings of these
studies, including those of near-ultraviolet (UV) CD mea-
surements (Peyser et al., 1997), kinetics of modification of
Cys707 (Phan et al., 1997) and Lys84 (Ajtai et al., 1999),
mostly supported the conclusions of the results obtained
with the recombinant truncated Dictyostelium S1 (Fisher et
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al., 1995; Smith and Rayment, 1996), i.e., S1.ADP.BeFx
resembled the M*.ATP whereas S1.ADP.AlF4 and
S1.ADP.Vi mimicked the M**.ADP.Pi intermediate state.
However, beside similarities, differences were also found in
the solution studies between the structure of the PA-con-
taining complexes and that of the intermediate states of the
ATP hydrolysis.
Because of the inconsistent results about the resemblance
of S1.ADP.BeFx complex to the intermediates of the
ATPase cycle, it seemed to us of interest to study why this
complex mimics the M*.ATP state in Dictyostelium and
rabbit S1, and the M**.ADP.Pi state in smooth muscle S1.
The conflicting results may derive from differences between
S1’s obtained from various sources or from the different
conditions used for crystallization and solution studies. The
first possibility seems improbable in the light of a recent
preliminary communication where a crystal structure of
truncated Dictyostelium S1.ADP.BeFx complex resembling
the M**.ADP.Pi state was obtained (Holmes, 1998). 19F
NMR spectroscopy suggested that ADP.BeFx, trapped S1 in
0.18 M KCl, exists in more than one conformer, perhaps
mimicking both M*.ATP and M**.ADP.Pi (Henry et al.,
1993). If so, the various S1 crystals might select one of the
ADP.BeFx conformers mimicking either the M* or the M**
state, depending on which conformer is the predominant
form under the given conditions. A factor that may affect
the distribution between the two conformers is ionic
strength, because the crystals of smooth muscle
S1.ADP.BeFx were grown at high ionic strength (1.8 M
ammonium sulfate) (Dominguez et al., 1998) and those of
Dictyostelium S1.ADP.BeFx in a moderate ionic-strength
medium in the presence of polyethylene glycol (Fisher et
al., 1995).
Because we found in preliminary studies (Peyser et al.,
1999) that the resemblance of S1.ADP.BeFx to transient
conformations occurring during ATP hydrolysis is ionic-
strength-dependent, we decided to generalize the investiga-
tion to the effect of ionic strength on the structure, forma-
tion, and dissociation of various S1–nucleotide complexes.
We studied the effect of ionic strength on the conformation
of rabbit skeletal S1 complexed with various nucleotides
and phosphate analogs in solution. Several methods were
used, including the measurement of rates of modification of
Cys707 (SH1 thiol) and Lys84 (reactive lysine residue), rate
of dissociation of the stable S1.ADP.Vi complex, trypto-
phan fluorescence intensity increment and near-UV CD
spectra. High ionic strength was found to influence the
conformation of the S1 complexes and to shift the equilib-
rium of the S1.ADP.BeFx conformers from predominantly
resembling M*.ATP to predominantly resembling
M**.ADP.Pi. We studied why the increasing ionic strength
abolishes the M* intermediate structure in favor of a struc-
ture most closely resembling the M** intermediate. Be-
cause higher ionic strength weakens salt bridges, the possi-
bility was considered that the stability of the induced M*
conformation is due to formation of salt bridges that are
broken during the structural transition from M* to M**
accompanying ATP hydrolysis. We have identified possible
salt bridges participating in this proposed process by com-
paring the available crystal structures of the M* and M**
intermediates.
MATERIALS AND METHODS
Chemicals
ATP, ADP, TNBS, BeCl2 (dissolved in 1% HCl), -chymotrypsin, dithio-
erythritol, HEPES, phenylmethane sulfonyl fluoride, and TrisHCl were
from Sigma (St. Louis, MO). ATPS was purchased from Boehringer
Mannheim (Indianapolis, IN). The ADP contamination of the ATPS is
less than 5% according to polyethyleneimine cellulose thin layer chroma-
tography. CPM was from Molecular Probes (Eugene, OR). All other
chemicals were reagent grade. A stock solution of sodium vanadate (100
mM) was prepared according to Goodno (1979). Sodium fluoride stock
solutions were prepared on the day they were used.
Preparation of proteins
Myosin was prepared from back and leg muscles of rabbit by the method
of Tonomura et al. (1966). S1 was obtained by digestion of myosin
filaments with -chymotrypsin as described by Weeds and Taylor (1975).
Protein concentrations were obtained by absorbance, using an A(1%) at
280 nm of 5.5, and 7.5 for myosin and S1, respectively. Molecular masses
were assumed to be 500 and 115 kDa for myosin and S1, respectively.
Formation of stable S1.ADP.phosphate analog
complexes (trap formation)
S1 (17–30 M) was incubated in 10 mM or 500 mM KCl, 1 mM MgCl2,
and 30 mM HEPES, pH 7.0 at 25°C with 0.2 mM ADP for 5 min. In the
case of BeFx, or AlF4 containing complexes, 5 mM NaF was also present.
After that time, 0.2 mM of Vi, BeCl2, or AlCl3 was added, and the
incubation continued at 25°C for 20 min. When studying the formation of
the “trapped” S1.ADP.Vi complex, aliquots were taken at given time
intervals after addition of Vi to assay K-(EDTA)-activated ATPase ac-
tivity.
K-(EDTA)-activated ATPase assay
This was assessed from the inorganic phosphate produced, measured by
malachite green assay according to Kodama et al. (1986). The reaction was
performed at 25°C on 0.5 mL aliquots taken at various time intervals.
Incubation times were chosen so that no more than 15% of the ATP was
hydrolyzed. The assay contained 1 M S1, 2 mM ATP, 6 mM EDTA, 600
mM KCl, and 50 mM Tris-HCl buffer, pH 8.0.
Decomposition of the stable
S1.MgADP.Vi complex
This was followed essentially according to Peyser et al. (1996) by EDTA
chase. The metal ions, which have been dissociated from the
S1.MgADP.Vi complex, are chelated with EDTA that reacts only with free
Me2 but not with Me2 trapped in the complex. The EDTA-chelated
Me2 cannot reenter the complex, which decomposes in the absence of
divalent cation. The S1.MgADP.Vi complex was incubated at 25°C in the
presence of 4 mM EDTA and the decomposition of the complex was
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followed by measuring the recovery of the K-(EDTA)-activated ATPase
activity as described above.
Kinetics of S1 modification
The time course of trinitrophenylation of Lys84 was spectrophotometrically
followed essentially as described earlier (Muhlrad and Takashi, 1981).
TNBS (final concentration 100 M) was added to 10 M S1 in the
presence or absence of nucleotides in 1 mM MgCl2, 30 mM TrisHCl, pH
7.8, and either 10 mM KCl or 500 mM KCl. The reaction was performed
in the absence or presence of nucleotides (0.2 mM ADP, 6 mM ATP, 0.2
mM ATPS) bound to the active site or after active site trapping with
MgADP and Vi, BeFx, or AlF4. The reaction was carried out in a
thermostated cell of a Unikon 810P spectrophotometer (Zurich, Switzer-
land) at 25°C. The absorbance change at 345 nm was recorded and the
number of TNP groups introduced was calculated. The reaction of S1 with
the TNBS has fast and slow components (Kubo et al., 1960). In the fast
reaction, the trinitrophenylation of Lys84 and the rest of S1 lysines takes
place, whereas, in the slow reaction, only the rest of the S1 lysines are
modified. Under the conditions of the measurements, trinitrophenylation of
Lys84 is essentially finished during the first 10–20 min of the reaction.
Initial velocity of the modification of the slowly reacting lysines, v2, was
calculated from the reaction rate at 30 min after addition of TNBS by
accounting for changes in TNBS and unmodified lysine concentrations
during the first 30 min of the reaction. Initial velocity of trinitrophenylation
of Lys84 (v1) was obtained by subtracting v2 from the initial velocity of the
overall process (v). Because the modification of Lys84 is a pseudo first-
order reaction under the conditions of the experiment (10-fold molar excess
of TNBS over S1), the first-order rate constants could be calculated
from v1.
The time course of the reaction of Cys707 (SH1) with CPM was
followed as described recently (Phan et al., 1997) by monitoring the
fluorescence change accompanying the modification at 20°C in a thermo-
stated cell holder of a PTI Spectrofluorometer at excitation and emission
wavelengths of 390 and 475 nm, respectively. In these measurements, 0.5
M CPM was added to 5 M S1 in the presence or absence of nucleotides
(nucleotide concentration as during trinitrophenylation, except ATP, which
was 0.5 mM) and 30 mM HEPES, 1 mM MgCl2, pH 7.0, and either 10 or
500 mM KCl. A 10-fold molar excess of S1 over CPM was used in the
experiment to limit the reaction to 10% of the protein population. This
limits the modification to the highly reactive SH1 thiol and excludes the
reaction with SH2 (Phan et al., 1997). Under these conditions, both in the
presence and absence of nucleotides and phosphate analogs, the reaction of
SH1 with CPM can be described by a single exponential from which the
rates of SH1 modifications were calculated.
Circular dichroism
Near-UV CD spectra were recorded on a JASCO J715 spectropolarimeter
(Tokyo, Japan) as described earlier (Peyser et al., 1997). Protein spectra
measurements were carried out in a 1-cm thermostated cell at 20°C
containing 20 M S1, 30 mM HEPES at pH 7. The buffer also contained
various concentrations of KCl to alter ionic strength. In addition, some
samples contained nucleotides and phosphate analogs as described in
Kinetics of S1 modification. In samples containing ATP, an ATP-regen-
erating system (5 M pyruvate kinase and 5 mM phosphoenolpyruvate)
was added to keep the ATP concentration constant. To obtain a spectrum,
CD was recorded from a sample containing the S1 complex, and, sub-
tracted from this was a similarly recorded spectrum from an identical
sample except without protein. The CD spectra are expressed as extinction,
 (M cm)1,
 

32980 Cl (1)
where  is mdeg, l is the optical path length in cm, C is the molar
concentration of S1.
Nucleotide-induced tryptophan
fluorescence increment
Tryptophan fluorescence of 1 M S1 in 30 mM HEPES, 1 mM MgCl2, pH
7.0 and either 10 or 500 mM KCl was recorded at 20°C before (F0) and
after (F) addition of nucleotides and phosphate analogs (for concentrations,
see Kinetics of S1 modification except for ATP, which was 0.5 mM) in a
thermostated cell of a PTI spectrofluorometer. Excitation and emission
were set at 297 and 332 nm, respectively. The fluorescence intensity
increments induced by nucleotides and phosphate analogs were expressed
as percent of fluorescence increment, (F  F0) 100/F0.
Decomposition of heterogeneous S1
conformations into elementary forms
We compared the CD spectrum from S1ATP to that from S1, S1.ATPS,
S1.ADP.AlF4, and S1.ADP to estimate the fractional contributions from
the ATPase intermediates, M, M*.ATP,M**, and M*.ADP, as described
previously (Peyser et al., 1997).
The S1.ADP.BeFx conformation was decomposed into contributions
from the M*.ATP and M** transient intermediate conformations using the
formula,
E(S1.ADP.BeFx) a1E(S1.ATPS)
 a2E(S1.ADP.PA), (2)
where E is a signal derived from a variety of sources described below, a1
and a2 are the fractional concentrations for the M*.ATP and M** confor-
mations, and PA is AlF4 or Vi. In addition to Eq. 2, we always require
a1 	 0, a2 	 0, and a1  a2 
 1. With Eq. 2, we presume that S1.ATPS
and S1.ADP.PA induce pure M*.ATP and M** conformations.
Signals represented by E include the fluorescence increment, the mod-
ification rate of Lys84, or the near-UV CD spectrum. Only S1.ADP.AlF4
was used to model the M** conformation near-UV CD spectrum because
the S1.ADP.Vi spectrum contains contributions from the bound Vi (Ajtai
et al., 1998). The fluorescence increment and modification rate signals
provide single constraints on unknowns a1 and a2, and, consequently,
cannot determine both coefficients independently. In these cases, we as-
sume a2  1  a1, i.e., that the S1.ADP.BeFx conformation is faithfully
described by a mixture limited to the conformations induced by S1.ATPS
and S1.ADP.PA. CD spectra signals provide multiple constraints (one at
each point in the observed wavelength domain) for unknowns a1 and a2
such that these unknowns may be determined independently by least
squares. If the sum a1  a2  1, the remainder 1  (a1  a2) is that part
of the distribution of conformations in S1.ADP.BeFx that cannot be mod-
eled with S1.ATPS or S1.ADP.AlF4. We found, in all cases tested, that
a1 a2 1, suggesting a mixture limited to the conformations induced by
S1.ATPS and S1.ADP.PA, faithfully describes the distribution of confor-
mations in S1.ADP.BeFx.
Effect of neutral salts on protein structure
The presence of small charged atoms or molecules in the buffer weakens
the accessible ionic interactions within myosin by interposing themselves
between the interacting groups. Accordingly, we consider the possibility
that increasing ionic strength weakens salt bridges in the myosin that
stabilize the M*.ATP conformation in S1.ADP.BeFx. Different neutral
salts are also known to promote or destabilize hydrophobic interactions in
proteins according to the Hoffmeister/Von Hippel series (Von Hippel and
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Wong, 1964; Creighton, 1993; Green, 1932). Consequently, we must also
consider the possibility that increasing ionic strength affects hydrophobic
interactions in the myosin. We investigated the nature of the ionic strength
effect on S1 by observing how it differs for various neutral salts in the
Hoffmeister/Von Hippel series. The ions from the neutral salt bind to S1
according to
T Aº B
SCHEME 2
where T is a free-ion binding site on S1, A is the ion, and B is the occupied
ion-binding site. The concentration of binding sites is a constant, [N] [T]
 [B], where [ ] implies concentration. At equilibrium, if p is the fraction
of occupied sites,
p
A	/

1 A	/
 (3)
where 
  [T]eq[A]eq/[B]eq is the equilibrium constant. A signal, F,
sensitive to protein conformation, depends on ionic strength by
FA	 F0 F0 p
  
F0 
1 A	/
 (4)
where  is the signal level unaffected by ion binding. If 
 or F(0)   are
affected by the stability of the hydrophobic interactions in S1, then they
will be systematically perturbed by the neutral salts in the Hoffmeister/Von
Hippel series.
Identification of salt bridges in the M* and M**
complexes
Potential salt bridges were identified by measuring distances between
side-chain oxygen atoms in the negatively charged residues glutamate
(OE1 or 2) or aspartate (OD1 or 2) and the side-chain nitrogen atoms in the
positively charged residues lysine (NZ), arginine (NH1 or 2), or histidine
(ND1 or NE2). For our purposes, oppositely charged atoms from these
residues that are separated by 5 Å qualify as a salt bridge. This criterion
was applied to myosin S1 crystal structures from Dictyostelium discoi-
deum (S1dC) and smooth muscle (SmS1). Crystal structures representing
the myosin M* intermediate are MgADP.BeFx trapped (Fisher et al., 1995)
or MgATPS bound (Gulick and Rayment, 1997) S1dC. Crystal structures
representing the M** intermediate are MgADP.AlF4 (Fisher et al., 1995)
or MgADP.Vi trapped (Smith and Rayment, 1996) S1dC. To identify
potential salt bridges in the M** intermediate corresponding to residues in
the lever arm that are not in the S1dC structures, we consulted the crystal
structure of MgADP.AlF4-trapped SmS1 (Dominguez et al., 1998).
RESULTS
Trinitrophenylation of Lys84
Lys84 is the most reactive lysine residue of the myosin head
(Kubo et al., 1960) located in the 27-kDa N-terminal seg-
ment of the molecule (Mornet et al., 1980; Hozumi and
Muhlrad, 1981) at an interface of the catalytic and lever arm
domains (Ajtai et al., 1999). TNBS preferentially trinitro-
phenylates Lys84. The rate of reaction of Lys84 with TNBS
is three orders of magnitude faster than the rest of the lysine
residues of S1 (Muhlrad and Takashi, 1981). The trinitro-
phenylation of S1 takes place in two phases. The rapid first
phase of the reaction is from modification of both Lys84 and
the other lysines of S1 (Muhlrad and Takashi, 1981; Tono-
mura et al., 1963). This is followed by a slower second
phase after completion of Lys84 trinitrophenylation when
only the other lysines of S1 are reacting. The modification
of Lys84, but not the rest of lysine residues of S1, is strongly
inhibited by ATP and ATP analogs (Tonomura et al., 1963;
Muhlrad and Fabian, 1970).
We followed the kinetics of S1 trinitrophenylation in the
absence of nucleotide; in the presence of ATP, ADP, and
ATPS; and trapped with ADP.BeFx, ADP.AlF4, and
ADP.Vi in the presence of TrisHCl buffer, pH 7.8, and
either 10 or 500 mM KCl. The pseudo first-order rate
constants for modification of Lys84 were calculated from the
time courses of each reaction (see Materials and Methods)
and are shown in Table 1. At low ionic strength, all ligands
strongly inhibited the rate of trinitrophenylation of Lys84
without affecting the rate of modification of other lysine
residues. On the basis of the extent of inhibition, the ligands
are classified into two groups. ADP, ATPS, and
ADP.BeFx belong to the first group with 51–60%, and ATP,
ADP.AlF4 and ADP.Vi to the second group with 75–78%
inhibition, all in agreement with our previous results (Ajtai
et al., 1999). In the presence of MgATP, S1 predominantly
populates the M**.ADP.Pi state of the ATPase cycle (Bag-
shaw and Trentham, 1974). Because ADP.AlF4 and
ADP.Vi behave like ATP regarding the inhibition of Lys84
modification, it follows that the structure of S1.ADP.AlF4
and S1.ADP.Vi complexes in the vicinity of Lys84 resemble
the structure of the M**.ADP.Pi state. The results indicate
that, under the conditions of the experiment, the structure of
S1.ADP.BeFx in the vicinity of Lys84 is similar to the
structure of S1.ATPS. Thus, like S1.ATPS (Goody and
Hofmann, 1980), S1.ADP.BeFx resembles the structure of
M*.ATP. Addition of 500 mM KCl increases the rate of the
reaction in the presence of each ligand, except with
ADP.BeFx, where the rate of trinitrophenylation decreases
and approaches the rate observed in the presence of ATP,
TABLE 1 Pseudo first-order rate constants for
trinitrophenylation of Lys84 in S1 in the absence and presence
of nucleotides and phosphate analogs
Addition to S1
Rate constant  SE  105 (sec1)
or inhibition in %*
10 mM KCl 500 mM KCl
none 524  11.3 0 682  9.9 0
ADP 261  9.1 51 326  10.5 53
ATPS 265  15.9 50 517  10.9 24
ADP.BeFx 211  9.7 60 147  1.6 79
ATP 134  2.4 75 154  3.3 78
ADP.AlF4 120  2.3 78 172  4.1 75
ADP.Vi 129 3.1 76 147  16.2 79
*Mean  SE of six independent experiments.
Experimental conditions are discussed in Materials and Methods.
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ADP.AlF4, and ADP.Vi (75–79% inhibition). This shows
that, at high ionic strength, the structure of S1.ADP.BeFx in
the vicinity of Lys84 resembles that of the M**.ADP.Pi
state.
Alkylation of Cys707 (SH1) by CPM
The kinetics of Cys707 modification with CPM was fol-
lowed by fluorescence increase, which can be described by
a single exponential when the reaction was carried out in the
presence of 10-fold molar excess of S1 over the reagent.
The modification was performed in the presence and ab-
sence of nucleotides and phosphate analogs and the appar-
ent first-order rate constants determined as described previ-
ously (Phan et al., 1997) (Table 2). When the reaction was
carried out at low ionic strength, the rate of the reaction was
low in the presence of ATP and ADP.Vi, i.e., in cases where
S1 is in the M**.ADP.Pi state, and in the absence of
nucleotides. The reaction was fast in the presence of
ATPS, i.e., in the M*.ATP state, and with ADP, whereas,
with ADP.BeFx, intermediate velocity was obtained, which
was nearer to the rate observed with ATPS than to the rate
with ATP. These results are in accordance with those ob-
tained in an earlier study (Phan et al., 1997). At high ionic
strength, the rate of reaction became much faster in all
cases. The velocity at high ionic strength decreased in the
order ATPS  ADP  ADP.BeFx  ADP.Vi  no
nucleotide  ATP but the measured reaction rate differ-
ences between the various cases became significantly
smaller than the differences obtained in the presence of low
ionic strength buffer.
Nucleotide-induced tryptophan
fluorescence increment
Addition of ATP or ADP to S1 causes a significant increase
in tryptophan fluorescence intensity (Werber et al., 1972).
ATP induces about a 25% increment, but increments in-
duced by ADP or ATPS (Goody and Hofmann, 1980) are
much smaller. According to recent studies (Johnson et al.,
1991; Batra and Manstein, 1999; Onishi et al., 2000; Park
and Burghardt, 2000; Yengo et al., 2000) Trp510 is the
nucleotide-sensitive tryptophan in S1. We studied the tryp-
tophan fluorescence increment induced by addition of ADP
and phosphate analogs to S1 (Werber et al., 1992) and found
that ADP.AlF4 causes about the same increment as ATP,
but the increase induced by ADP.BeFx was considerably
smaller. In this work, we studied the effect of high KCl
concentration on the tryptophan fluorescence of S1 and
compared the tryptophan fluorescence increment caused by
the addition of nucleotides and PAs at high and low ionic
strength. Tryptophan fluorescence of S1 was reduced only
by 3–4% in the absence of nucleotides at high ionic
strength, which may reflect to a weak quenching effect of
high KCl concentration (data not shown). The effect of ionic
strength on the nucleotide-induced fluorescence increment
was more significant (Table 3). At low ionic strength, the
highest increment was obtained by ADP.AlF4, which was
closely followed by ATP. The lowest increments were ob-
served with ADP and ATPS, whereas the ADP.BeFx in-
crement was intermediate but closer to ATPS than to ATP.
The results indicate that ADP.AlF4 mimics the
M**.ADP.Pi state but that ADP.BeFx probably exist in two
conformer forms, one mimicking the M**.ADP.Pi and the
other the M*.ATP state with the equilibrium favoring the
latter. At high ionic strength, the fluorescence increments
induced by all nucleotides except ADP.AlF4 became sig-
nificantly higher and the contrast among the different states
significantly smaller. The tryptophan fluorescence in the
presence of ADP.BeFx at high ionic strength is nearer to that
observed with ATP or ADP.AlF4 than with ATPS. This
suggests that, at high ionic strength, the equilibrium be-
tween the two ADP.BeFx conformers is shifted to the di-
rection of the M**.ADP.Pi form.
Effect of ionic strength on the near-UV CD
spectrum of S1 in the presence of nucleotides
and PAs
The near-UV CD spectrum of S1 between 250 and 310 nm
is dominated by contributions from the aromatic amino acid
residues. The 255–270-, 270–275-, 275–285-, and 285–
TABLE 2 Effect of ionic strength on the rate constants
of alkylation with CPM of Cys707 in S1 and
nucleotide–S1 complexes
Addition to S1
Rate constant  SE 103 (sec1)*
10 mM KCl 500 mM KCl
None 9.1  0.77 18.2  1.62
ADP 13.0  0.952 21.7  1.86
ATPS 13.9  1.06 22.7  2.04
ADP.BeFx 11.3  0.99 21.1  1.94
ATP 8.7  0.76 15.5  1.37
ADP.Vi 8.3  0.72 19.2  1.78
*Mean  SE of five independent experiments.
Experimental conditions are discussed in Materials and Methods.
TABLE 3 Effect of ionic strength on the nucleotide-induced
tryptophan fluorescence increment in S1
Addition to S1
Fluorescence increment* (%)
10 mM KCl 500 mM KCl
ADP 5.8  0.1 12.4  0.2
ATPS 9.1  0.4 17.4  1.5
ADP.BeFx 14.0  0.6 24.5  0.3
ATP 25.1  0.8 27.2  0.2
ADP.AlF4 26.6  0.4 26.4  0.3
*Mean  SE of four independent measurements.
Experimental conditions are discussed in Materials and Methods.
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310-nm regions are generated by Phe, Tyr, Tyr, and Trp
together, and Trp chromophores, respectively (Strickland,
1974). We found recently that addition of nucleotides and
PAs significantly affect the near-UV CD spectrum of S1 at
low ionic strength (Peyser et al., 1997), likely through the
nucleotide-sensitive tryptophan Trp510 (Park et al., 1996)
and possibly through the interaction of the adenine ring of
the nucleotides with the aromatic Tyr135 and Trp131 residues
in the active site of S1 (Strickland, 1974). The various
nucleotides and PAs differently affect the near-UV CD
spectrum of S1 and characterize the intermediate conforma-
tions of S1 during ATPase.
The near-UV CD of S1MgATP is a sum of spectra
from the transient intermediates M*.ATP, M**.ADP.Pi,
and M*.ADP with weights corresponding to their fractional
concentrations. These intermediates are modeled by the
analog conformations S1.ATPS or S1.ADP.BeFx,
S1.ADP.AlF4, and S1.ADP, respectively, from which we
computed the fractional concentrations with a method de-
scribed previously (Peyser et al., 1997). The fractional oc-
cupation of the transient intermediates observed with CD
agrees with earlier results from time resolved experiments
(Bagshaw and Trentham, 1974) indicating M** accounts
for80% of the transient population. We also found that, at
low ionic strength, the S1.ADP.BeFx and S1.ATPS spectra
are very similar, both mimicking the M*.ATP intermediate.
In this work, we studied the influence of nucleotides and
PAs on the near-UV CD spectrum of S1 at high ionic
strength (Fig. 1). All the nucleotides and PAs affected the
spectrum, however, the contrast among their effects dimin-
ishes with increasing ionic strength. Nevertheless, the cal-
culated fractional concentrations of the transient intermedi-
ate states in S1MgATP indicated the M**.ADP.Pi state is
predominant, accounting for 61% of the total population,
with the remainder in M*.ATP. In this calculation, M*.ATP
and M**.ADP.Pi are modeled with S1.ATPS and
S1.ADP.AlF4, respectively. If S1.ADP.BeFx replaces
S1.ATPS as the model for M*.ATP, the M**.ADP.Pi and
M*.ATP states account for 52 and 46% of the population
with the remainder in the M*.ADP state. The predominance
of the M**.ADP.Pi state, at 80% at low ionic strength,
diminishes to 60% at high ionic strength. This may be an
accurate representation of the state distribution during
ATPase or caused by the lower contrast among the analog
CD spectra leading to ambiguous assignments of distribu-
tion coefficients.
Finally, expanding the S1MgATP spectrum in terms of
the analog spectra from S1.ATPS, S1.ADP.BeFx, and
S1.ADP, all at high ionic strength, produces fractional con-
centrations of 33, 67, and 0% of the total population. The
latter results, obtained using S1.ADP.BeFx to replace
S1.ADP.AlF4 in the analysis of S1MgATP, hints that
S1.ADP.BeFx is an M**.ADP.Pi analog in these conditions.
We tested the heterogeneity of the near-UV CD spectrum
from S1.ADP.BeFx as a function of ionic strength using Eq.
2. The CD results at 500 mM KCl are computed from the
spectra in Fig. 1, spectra at other ionic strengths are not
shown. These CD results are summarized in Table 4, where
we show that, for increasing ionic strength, S1.ADP.BeFx
changes from a predominantly M*.ATP to a predominantly
M**.ADP.Pi analog. In contrast, if we perform a similar test
on the S1.ATPS analog, where, in Eq. 2, we reverse the
roles of S1.ADP.BeFx and S1.ATPS, we find a2 0 for all
signals, implying that S1.ATPS has no overlap with the
pure M**.ADP.Pi analog regardless of ionic strength.
Heterogeneity of the S1.ADP.BeFx conformation
We tested the heterogeneity of the S1.ADP.BeFx conforma-
tion as a function of ionic strength with Eq. 2 using the
fluorescence increment and the modification rate of Lys84
as the signal sources (data from Tables 1 and 3). The results,
FIGURE 1 Near-UV CD spectra of S1 and S1-nucleotide complexes in
the presence of 500 mM KCl. Top: S1 (—), S1.ADP (F), and
S1.ADP.BeFx (}). Bottom: S1.ATPS (Œ), S1.ADP.BeFx (}),
S1.ADP.AlF4 (E), and S1ATP (). Top and bottom panels have dif-
fering wavelength domains. Spectra from the trapped nucleotide analogs
and S1ATP collected in the bottom panel are essentially indistinguish-
able over wavelengths 270 nm
  
 310 nm. Experimental conditions are
described in Materials and Methods.
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tabulated in Table 4, closely follow those indicated by the
near-UV CD spectrum of S1.ADP.BeFx.
Effect of ionic strength on the formation and
dissociation of the stable S1.MgADP.Vi complex
The formation of the “trapped” S1.MgADP.Vi complex is
accompanied by the loss of ATPase activity that recovers
with dissociation of the complex (Goodno, 1979). Thus, we
conveniently monitored formation and dissociation of the
complex by measuring K(EDTA)-activated ATPase. For-
mation of the S1.MgADP.Vi complex was achieved by
adding vanadate to S1 in the presence of saturating concen-
trations of ADP and MgCl2 at various ionic strengths. Under
these conditions, the formation of the complex can be de-
scribed by the scheme (Werber et al., 1992),
S1.MgADPVi¢O¡
k1
k1
S1.MgADP.Vi ¢O¡
k2
k2
S1#.MgADP.Vi.
SCHEME 3
The first step is assumed to be a rapid binding equilibrium
that is followed by a slow isomerization step. S1# indicates
an altered conformation. The ionic strength during the for-
mation reaction was defined by increasing concentrations of
KCl or K-acetate (Fig. 2, A and B, respectively). The time
course of ATPase disappearance in each case was fitted to
a single exponential and characterized by a first-order ki-
netic constant, kobs. The obtained kobs values are plotted in
Fig. 3. Ionic strength higher than 200 or 350 mM strongly
inhibited the formation of the S1.MgADP.Vi complex with
KCl and K-acetate, respectively.
According to Scheme 3, and because the first step is
always at equilibrium with constant K1  k1/k1, kobs is, in
general, a function of K1 and the forward and backward
rates of isomerization, k2 and k2. The stability of the
vanadate-trapped S1 (see below) is such that k2 may be
neglected and kobs depends on K1 and k2 alone. Whether
ionic strength affects K1 and k2 was investigated using the
dependence of kobs on vanadate concentration, [Vi] (Fig. 4).
The kobs versus [Vi] curves at two KCl concentrations were
fitted with hyperbolas from which k2 (kobs for [Vi]3 ) and
K1 ([Vi] at which kobs 1⁄2k2) values were calculated. At 10
or 500 mM KCl, k2 is 1.91 or 0.26 sec1, and K1 is 0.18 or
0.14 mM, respectively. The results show that k2 is very
dependent, whereas K1 is comparatively independent of KCl
concentration. Thus, ionic strength dramatically affects the
slow isomerization step in Scheme 3 but not the transient
binding of the PA.
We also studied the effect of the ionic strength of the
spontaneous dissociation of the S1.MgADP.Vi complex by
EDTA chase as described in Materials and Methods. The
time course of the dissociation of S1.MgADP.Vi in the
presence of various concentrations of KCl or K-acetate was
followed by monitoring the recovery of the K(EDTA)-
activated ATPase activity and presented in Fig. 5, A and B.
Increasing concentrations of KCl and K-acetate strongly
inhibited the rate of the ATPase recovery, i.e., the dissoci-
ation of the complex. The inhibition of the ATPase recovery
is not due to denaturation of S1 during the long incubation
at 20°C at high salt concentration because addition of actin
causes the fast dissociation of the complex (Werber et al.,
1992) and the full recovery of ATPase activity (results not
shown). Thus the results indicate that the increasing ionic
strength significantly enhances the stability of the
S1.MgADP.Vi complex and, therefore, that of the
M**.ADP.Pi state.
Effect of Hoffmeister/Von Hippel series neutral
salts on the stability of the M**.ADP.Pi
conformation
We observed the effect of ionic strength on the rate of
formation of the S1.MgADP.Vi complex for various neutral
salts in the Hoffmeister/Von Hippel series (Von Hippel and
Wong, 1964; Green, 1932). As before, the time course of
ATPase disappearance accompanying stable trap formation
was fitted to a single exponential and characterized by a
first-order kinetic constant, kobs. The neutral salts investi-
gated, listed in decreasing order for their ability to stabilize
hydrophobic interactions in proteins, were K-acetate, NaCl,
KCl, KBr, KI, and KSCN. Available data suggests that
NaCl and KCl may be equivalent perturbants (Von Hippel
and Wong, 1964) of hydrophobic interactions in proteins,
whereas other data suggests that KCl is the more potent
perturbant (Green, 1932). The kobs versus salt concentration
for K-acetate (■) and KCl () are shown in Fig. 3.
The effect of salt concentration on kobs is described by
Eq. 4 with the two parameters 
, and kobs(0)  , corre-
sponding to the ion binding constant and the ion-binding
sensitive part of the rate of ATPase change. In Fig. 6, we
summarize the values of these parameters computed from
the data in Fig. 3 and that from the other ions in the
TABLE 4 Heterogeneity of the ADP.BeFx analog as a
function of ionic strength*
KCl
(mM) Signal† % M*.ATP % M**
10 trinitrophenylation 63 37
F 72 28
CD 87 13
60 CD 35 65
100 CD 17 83
500 trinitrophenylation 0 100
F 21 79
CD 14 86
*Experimental error for the fractional concentrations is 
10%.
†Trinitrophenylation is TNBS modification of Lys84. F  100(F 
F0)/F0 where F is the analog trapped or nucleotide bound, and F0 is
substrate free, S1 tryptophan fluorescence. CD is the near-UV CD spec-
trum.
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FIGURE 2 The time course of
K(EDTA)-activated ATPase disappear-
ance during vanadate trapping. Effect of
(A) KCl or (B) K-acetate concentration on
trap formation. For details of trap forma-
tion and ATPase measurement see Mate-
rials and Methods.
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Hoffmeister/Von Hippel series. Figure 6 shows that ion-
dependent parameters have no obvious dependence on the
order of the Hoffmeister/Von Hippel series salts, suggesting
that the S1 ionic strength effect pertains to electrostatic
rather than hydrophobic interactions in the protein. This
ionic strength effect, characteristic to S1 during the “salting-
in” phase of its solubility, depends on the concentration but
not the nature of the neutral salt. The “salting-out” effect,
known to depend on the position of the neutral salt in the
Hoffmeister/Von Hippel series, apparently begins to be
relevant only at higher salt concentrations (Green, 1932).
Involvement of salt bridges in the stabilization of
the M*.ATP state
We found in this study that, in the S1.ADP.BeFx complex,
the M*.ATP conformation is destabilized at high ionic
strength in favor of the M**.ADP.Pi conformation. Our
results using the neutral salts from the Hoffmeister/Von
Hippel series suggests that this phenomenon originates from
the disruption of ionic, rather than hydrophobic, interactions
in the protein. Salt bridges are an important component of
the ionic stabilization energy in a protein and their disrup-
tion at high ionic strength might be responsible for the lower
stability of the M*.ATP conformation in these conditions.
We searched for possible candidate salt bridges stabilizing
M*.ATP in the available crystal structures of S1.
We began our search by identifying all oppositely
charged side-chain atoms from salt bridge-forming residues
separated by 5 Å. This criterion identifies about 100
potential salt bridges in S1 in each structure investigated.
We narrowed the field by making additional assumptions
about the properties anticipated for M*.ATP stabilizing
bridges. First, we assume that the salt bridges of interest are
not present in the M** intermediate, suggesting that we can
ignore any bridge common to both the M*.ATP and
M**.ADP.Pi conformations. Second, we assume that the
salt bridges of interest are necessary to stabilize M*.ATP
such that they must appear in any structural representation
of M*.ATP. By the second assumption, we ignore salt
bridges unique to M*.ATP that do not appear in both the
MgADP.BeFx trapped and MgATPS bound S1dC struc-
tures.
Given the above, we identified the 10 intradomain salt
bridges (numbering from S1dC) Asp21–Arg7, Glu99–Arg44,
Glu150–Arg147, Glu187–Arg131, Glu395–Lys391, Glu492–
Lys496, Asp509–Lys557, Asp718–Lys721, Asp724–Lys728,
Glu755–Arg704, and the three interdomain bridges Asp614–
Lys435, Glu755–Lys84, Glu756–Arg33. Intradomain salt
bridges link residues within one of the three domains des-
ignated as catalytic, converter, and lever arm (Geeves and
Holmes, 1999). Interdomain salt bridges link together any
two of these domains. The interdomain salt bridges identi-
fied link the converter and catalytic domains (Asp614–
Lys435) or the lever arm and catalytic domains (Glu755–
Lys84 and Glu756–Arg33).
We further narrow the field by requiring that the residues
engaged in a potential salt bridge are conserved between
S1dC and chicken skeletal S1 but allowing interchangeabil-
ity between Glu and Asp and among Lys, Arg, and His. This
restriction leaves us with a set of five possibilities: Glu150–
Arg147 (near-active site), Glu492–Lys496 (Switch II helix),
Asp718–Lys721 (converter domain), Glu755–Arg704 (lever
arm), and Glu755–Lys84 (lever arm to catalytic). The loca-
tion of two of these salt bridge pairs makes them remarkable
relative to the other pairs in the set. The Glu492–Lys496 pair
is located in the Switch II helix, at the heart of the energy
transduction mechanism. The Switch II helix deforms dur-
ing the M*.ATP to M**.ADP.Pi transition causing a 5-Å
displacement of the closest charged atoms in side chains
from Glu492 and Lys496 (from 3.7 to 8.8 Å). The Glu755–
Lys84 pair spans the catalytic and lever arm domains. Lys84
is the reactive lysine residue that, when modified, alters the
rate of ATP hydrolysis (Fabian and Muhlrad, 1968). Lever
arm swinging in the M*.ATP to M**.ADP.Pi transition
causes a 23-Å displacement of the closest charged atoms in
side chains from Glu755 and Lys84 (from 3.8 to 27.4 Å,
M**.ADP.Pi separation distance taken from SmS1
(Dominguez et al., 1998)). With chicken pectoralis myosin
sequence numbering, the salt bridge in the Switch II helix is
Glu501–Lys505 and the interdomain pair is Glu776–Lys84.
DISCUSSION
In this work, the effect of ionic strength on the structure of
S1 complexed with various nucleotides and PAs was stud-
ied. It was found that the increase of ionic strength,
achieved by increasing concentration of KCl, enhances the
accessibility of Cys707 and Lys84 residues to modifications
essentially in all S1-nucleotide complexes. Because Cys707
FIGURE 3 The observed rate of K-EDTA ATPase inhibition due to
vanadate trapping of S1 versus concentration of the neutral salts K-acetate
(■) and KCl (). Solid lines indicate a fitted curve derived from Eq. 4
where kobs replaces F([A]) at salt concentration [A]. The fitted parameters
for these curves are plotted in Fig. 6.
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and Lys84 are located at different regions of S1, this effect
suggests increased flexibility in the molecular structure with
increasing ionic strength.
In addition to the enhanced mobility of the molecule, we
found that the structure of the various states of the ATPase
cycle, represented by S1-nucleotide complexes, become
more similar at high ionic strength. This is manifested in the
similar rates of modification of Cys707 with CPM, in smaller
contrast among the near-UV CD spectra for the M*.ATP
and M**.ADP.Pi conformations, and in the more uniform
fluorescence increment upon nucleotide binding to, or nu-
cleotide analog trapping of, S1. The changes in the near-UV
CD spectrum possibly reflects altered local structure at the
nucleotide-sensitive tryptophan, Trp510, and in the active
site where the adenine ring of the nucleotide interacts with
local aromatic residues. Thus, the active site and the vicinity
of Cys707 and Trp510 may become less sensitive to the
differences among the states of the ATPase cycle at high
ionic strength. Alternatively, the contrast among the rates of
trinitrophenylation of Lys84 for the various nucleotide–S1
complexes is about the same at low and high ionic strength,
indicating that the similarity of the S1 ATPase intermediates
does not carry over to the vicinity of Lys84.
The increase in ionic strength significantly enhances the
nucleotide-induced tryptophan fluorescence increment with
all nucleotides and PAs used in this study (except AlF4),
but it only slightly reduces tryptophan fluorescence in the
absence of nucleotides (data not shown). Chymotryptic S1
has five Trps and it is believed that essentially only the
fluorescence of Trp510 (Johnson et al., 1991; Batra and
Manstein, 1999; Onishi et al., 2000; Park and Burghardt,
2000; Yengo et al., 2000) is affected by nucleotides. The
slight decrease in the fluorescence of S1 tryptophans in the
absence of nucleotides may indicate a weak quenching by
high concentration of KCl, but the enhanced nucleotide-
induced fluorescence increment at high ionic strength points
to the moving of Trp510 to a more protected environment.
The results of the present work are in accordance with
former studies showing that, at low ionic strength,
S1.ADP.BeFx resembles the M*.ATP but S1.ADP.AlF4
and S1.ADP.Vi complexes mimic the M**.ADP.Pi states
(Fisher et al., 1995; Peyser et al., 1997; Phan et al., 1997;
Ajtai et al., 1999). The comparison of the rates of modifi-
cation of Lys84, the tryptophan fluorescence enhancement
increment, and the near-UV CD spectra of S1.ADP.BeFx to
that obtained from S1 in the M**.ADP.Pi and M*.ATP
FIGURE 4 Vanadate concentration dependence of the rate constant of S1.ADP.Vi complex formation, kobs, for two KCl concentrations.
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FIGURE 5 Effect of (A) K-acetate or (B) KCl concentration on the dissociation of the Vi from the S1.MgADP.Vi complex by EDTA chase.
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states show that the S1.ADP.BeFx structure more closely
resembles that of M*.ATP at low ionic strength. At high
ionic strength, these same indicators of protein structure
show that the S1.ADP.BeFx structure more closely resem-
bles that of M**.ADP.Pi. On the basis of these results we
propose that S1.ADP.BeFx at equilibrium exists in two
forms, one mimicking M*.ATP, the other M**.ADP.Pi.
This equilibrium is affected by ionic strength, in the manner
suggested by the variation in the fractional distribution of
the S1.ADP.BeFx between the M*.ATP and M**.ADP.Pi
conformers tabulated in Table 4. As such, low ionic strength
favors M*.ATP and high ionic strength the M**.ADP.Pi
form.
Our finding that, at high ionic strength, the M**.ADP.Pi
state is favored over the M*.ATP state is probably due to the
decreased stability of the latter state, which is supported by
the results of Johnson and Taylor (1978) who showed that
the M*.ATP to M**.ADP.Pi transition is accelerated at high
ionic strength. The shifting equilibrium from M*.ATP to
M**.ADP.Pi at higher salt concentration may explain the
apparent inconsistency of the crystallographic studies, i.e.,
the observation that the atomic structure of S1.ADP.BeFx
crystals grown at moderate ionic strength mimic M*.ATP
(Fisher et al., 1995) whereas those grown at high ionic
strength resemble the M**.ADP.Pi form (Dominguez et al.,
1998). Ions bind to S1 with a binding constant of 80 mM
(Table 4 or Fig. 6) shifting the M*ºM** equilibrium in
skeletal S1.ADP.BeFx. The crystallization of
S1dC.ADP.BeFx produces the M* conformation at moder-
ate salt concentrations (170 mM) where the predominant
conformation, based on the skeletal data, is expected to be
firmly on the M** side of the equilibrium. This apparent
discrepancy suggests that the S1dC.ADP.BeFx complex
binds salt with lower affinity than the skeletal S1.ADP.BeFx
complex. The salt-binding constants for these complexes
may differ due to experimental conditions (for instance
polyethylene glycol is present during crystallization of
S1dC.ADP.BeFx) or to more interesting structural differ-
ences, including lever arm length.
Neutral salt concentration alters S1.ADP.BeFx conforma-
tion through its effect on ionic and hydrophobic interactions
stabilizing the protein structure. The small charged atoms or
molecules from the neutral salt in the buffer suppress the
accessible ionic interactions within myosin by interposing
themselves between the interacting groups. Accordingly,
there is the possibility that increasing neutral salt concen-
tration weakens salt bridges in the myosin that stabilize the
M*.ATP conformation of S1.ADP.BeFx. Alternatively, neu-
tral salts are also known to systematically affect hydropho-
bic interactions according to the Hoffmeister/Von Hippel
series. Figure 6 indicates the effect of several neutral salts in
the Hoffmeister/Von Hippel series on the formation of the
S1.ADP.Vi complex. Each neutral salt affects the formation
rate of the stable complex in a concentration-dependent
manner. However, they behave rather similarly to each
other and show no apparent correlation with the Hoffmeis-
ter/Von Hippel series. On this basis, we conclude that
increasing neutral salt concentration mainly affects
S1.ADP.BeFx conformation by weakening the ionic inter-
actions in the protein structure.
If the dissolution of ionic interactions in S1.ADP.BeFx
causes movement of the predominant equilibrium structure
from one like M*.ATP to one like M**.ADP.Pi, solution-
exposed salt bridges in S1 might provide the energy-stabi-
lizing M*.ATP at low ionic strength. We inspected and
compared crystal structures for the M*.ATP and
M**.ADP.Pi intermediates to investigate this possibility.
The comparison yielded several pairs of residues potentially
forming salt bridges in M*.ATP that dissolve when S1
assumes the M**.ADP.Pi conformation. The residue pairs
fall into two classes that form links: within the catalytic,
lever arm, or converter domains (intradomain), or, between
any two of these three domains (interdomain). Inspection of
any of the intradomain salt bridges suggests that they work
to stabilize or rigidify domain structure. The interdomain
salt bridges appear to maintain relationships among the
domains characteristic to the structural intermediate.
We identified two salt bridge pairs, Glu501–Lys505 and
Glu776–Lys84, that seem most appropriate to consider for
participating in the ionic strength-induced M*.ATP to
M**.ADP.Pi transition. The Glu501–Lys505 intradomain
pair is in the Switch II helix responsible for perturbing the
ATP-sensitive tryptophan (Trp510) during ATP hydrolysis
(Geeves and Holmes, 1999; Onishi et al., 1998). Disturbing
the structure of this helix could induce structural changes
downstream in the energy transduction pathway, perhaps in
the converter domain, that mimic those needed for forma-
tion of the M**.ADP.Pi intermediate. The Glu776–Lys84
interdomain pair is a good choice for residues to directly
stabilize the M*.ATP intermediate due to their location at
FIGURE 6 Fitted parameters 
 (■), and {kobs(0)  } (), correspond-
ing to the ion-binding constant and the ion-binding sensitive part of the rate
of ATPase change for ions in the Hoffmeister/Von Hippel series. The data
used to find 
 and kobs(0)   for K-acetate and KCl are shown in Fig. 3.
NaCl and KCl may occupy identical positions on the x-axis (Von Hippel
and Wong, 1964).
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the extreme end of the lever arm (headed toward the C-
terminus) that can still interact with the catalytic domain. At
this point, the least force is needed to maintain a lever
arm–catalytic domain relationship characteristic to the
M*.ATP conformation. It is not surprising to us that Lys84
is involved in this interaction with the lever arm because we
have reported in the past on the ability of this residue, when
modified with TNP, to alter ATP hydrolysis rates by inter-
fering with lever arm movement (Ajtai et al., 1999).
We found that high ionic strength inhibits the association
and dissociation of the stable S1.MgADP.Vi complex mim-
icking the M**.ADP.Pi state, while other results indicate
that high ionic strength destabilizes M*.ATP. These effects,
produced by common mechanism, suggests that association
and dissociation of the stable S1.ADP.Vi complex depends
on the ability of the S1 to maintain an equilibrium between
structures that allow or inhibit active site analog association
and dissociation. Because increasing ionic strength causes
the inhibitory response, we associate it structurally with
M**.ADP.Pi, and conclude that it is a conformation closed
to substrate binding or release. Low ionic strength promotes
free association and dissociation of ADP.Vi with S1 and we
associate it structurally with M*.ATP, and conclude that it
is a conformation open to substrate binding or release. The
“open” and “closed” descriptors are analogous to those used
for the M*.ATP and M**.ADP.Pi crystal structures that are
based there on the open or closed conformation of the
hypothetical “back door” for phosphate release during hy-
drolysis (Geeves and Holmes, 1999; Yount, 1997). Possibly
these similarly characterized phenomena of S1 structure and
dynamics are related on a fundamental level. If so, then
ATP-driven conformational changes could promote the dis-
solution of certain salt bridges and the destabilization of
M*.ATP. In this scenario, the destabilization of M*.ATP is
the initiator of the “open” to “closed” structural transition
during energy transduction.
In conclusion, increasing ionic strength significantly af-
fects the structure of S1 and S1–nucleotide complexes. It
enhances the reactivity of functional groups, the stability of
the M**.ADP.Pi state, and the nucleotide-induced Trp flu-
orescence increment; and lowers the differences between
the structural intermediates of ATP hydrolysis in the vicin-
ity of Cys707, Trp510, and the active site. Increasing ionic
strength has a unique effect on the structure of
S1.ADP.BeFx complex, causing the destabilization of the
predominant M*.ATP intermediate and shifting the equilib-
rium to favor M**.ADP.Pi. The mechanism for destabiliz-
ing M*.ATP is the dissolution of ionic interactions, possibly
specific salt bridges. These ionic interactions appear to be
involved in the transition between the open (M*.ATP) and
closed (M**.ADP.Pi) forms of the S1.
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